Clinical trial
Aspirin for the Prevention of Recurrent Venous Thromboembolism
NCT00222677 · University Of Perugia, Other · Unknown status
Key facts
| NCT number | NCT00222677 |
|---|---|
| Title | Aspirin for the Prevention of Recurrent Venous Thromboembolism |
| Official title | Aspirin After Six Months or One Year of Oral Anticoagulants for the Prevention of Recurrent Venous Thromboembolism in Patients With Idiopathic Venous Thromboembolism. The WARFASA Study. |
| Lead sponsor | University Of Perugia, Other |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Venous Thromboembolism, Deep Venous Thrombosis, Pulmonary Embolism, Atherosclerosis |
| Intervention type | Drug |
| Interventions | aspirin |
| Enrollment | 70 |
| Start date | May 1, 2004 |
| Primary completion | Jan 1, 2012 |
| First posted | Sep 22, 2005 |
| Last update posted | Aug 23, 2011 |
| Countries | Austria, Italy |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: